BIOGENTS AG

Their core work

BIOGENTS AG is a German technology SME based in Regensburg that designs and manufactures scientific-grade insect traps, primarily for mosquito surveillance and vector control research. Their core product line — physical trap hardware — is used by public health agencies, research institutes, and environmental monitoring networks to count and identify disease-carrying mosquito species. In H2020, they both contributed specialist trap expertise to a major leishmaniasis control program and led the development of a smart IoT-connected trap station that automates remote mosquito counting and identification. They sit at the intersection of entomology hardware and digital monitoring infrastructure, translating field surveillance needs into deployable commercial products.

What they specialise in

How they've shifted over time

Both projects fall within a narrow 2015–2018 window, which limits true longitudinal analysis. Their earliest H2020 involvement (EUROLEISH-NET, 2015) was as a specialist partner in a research-driven disease control consortium, suggesting they entered the EU funding landscape by contributing product expertise to science-led programmes. Their second project (REMOSIS, 2016) marks a clear shift toward technology leadership: BIOGENTS took the coordinator role and drove an Innovation Action focused on commercialising smart, connected trap infrastructure. The trajectory — from research partner to innovation leader — is short but unambiguous.

BIOGENTS is moving from contributing specialist hardware to parasitic disease research toward leading product-driven IoT surveillance platforms, a direction that points to smart environmental monitoring and digital public health infrastructure as likely future collaboration territories.

How they like to work

BIOGENTS has taken on both leadership and partner roles, splitting evenly across their two projects — they coordinated the commercially oriented REMOSIS Innovation Action while joining EUROLEISH-NET as a specialist contributor. Despite being a small SME, they brought 29 unique consortium partners across 12 countries into just two projects, which suggests they operate as a well-networked connector rather than an isolated niche player. Working with them likely means access to a broad entomology and public health research network alongside a company that can deliver physical, deployable technology — not just research outputs.

BIOGENTS has collaborated with 29 unique partners across 12 countries — an unusually wide footprint for a two-project SME — reflecting both the multi-country nature of vector disease surveillance and their standing within European entomology and public health research networks.

What sets them apart

BIOGENTS occupies a rare niche: a commercial hardware manufacturer that operates fluently inside EU research consortia. Most insect trap suppliers remain outside the EU funding system; BIOGENTS has demonstrated the capacity to both lead Innovation Actions and contribute to fundamental research programmes, giving them credibility with scientists and a route to market that pure research partners lack. For a consortium building a project around vector surveillance, disease monitoring, or smart environmental sensing, BIOGENTS offers the combination of deployable product technology and research legitimacy that is difficult to find in a single SME partner.

Highlights from their portfolio

• REMOSIS
  BIOGENTS coordinated this Innovation Action — the highest-risk, commercially oriented project type — demonstrating their readiness to drive a product from concept to deployable IoT trap station, not merely contribute to someone else's research agenda.
• EUROLEISH-NET
  Participation in a major bench-to-bedside leishmaniasis control programme shows BIOGENTS' reach extends beyond mosquitoes into broader vector-borne parasitic disease ecosystems, connecting them to a different scientific community than their core mosquito trap work.